Literature DB >> 31075230

Role of identified RNA N6-methyladenosine methylation in liver.

Kechen Xu1, Yuchao Sun2, Baixiang Sheng2, Yiwen Zheng3, Xiaoli Wu2, Keyang Xu4.   

Abstract

N6-Methyladenosine (m6A) is the most abundant and important internal modification site of RNA methylation in viruses and eukaryotic. m6A RNA methylation plays key roles in the regulation of post-transcriptional gene expression, including messenger RNA (mRNA), microRNA (miRNA) and long noncoding RNA (lncRNA). And m6A methylation regulates the various aspects of RNA metabolism, including structure, maturation, stability, splicing, export, translation and decay. Liver is a vital metabolic and digestive organ in the pathophysiological processes. Recent studies suggested that m6A RNA modification highly regulates hepatic function and development of liver diseases. Here, we aim to summarize the biological and clinical significance of m6A modification in hepatic growth and hepatic disease including viral hepatitis, non-alcoholic fatty liver disease (NAFLD), and liver cancer.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Liver; Messenger RNA; Methylation; N6-methyladenosine; Noncoding RNA

Mesh:

Substances:

Year:  2019        PMID: 31075230     DOI: 10.1016/j.ab.2019.05.005

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  5 in total

1.  Fumonisin B1 alters global m6A RNA methylation and epigenetically regulates Keap1-Nrf2 signaling in human hepatoma (HepG2) cells.

Authors:  Thilona Arumugam; Terisha Ghazi; Anil A Chuturgoon
Journal:  Arch Toxicol       Date:  2021-01-26       Impact factor: 5.153

2.  The m6A reader YTHDF3-mediated PRDX3 translation alleviates liver fibrosis.

Authors:  Ruimin Sun; Xinyao Tian; Yang Li; Yan Zhao; Zhecheng Wang; Yan Hu; Lijun Zhang; Yue Wang; Dongyan Gao; Shusen Zheng; Jihong Yao
Journal:  Redox Biol       Date:  2022-06-24       Impact factor: 10.787

3.  Role of N6-Methyladenosine Methylation Regulators in the Drug Therapy of Digestive System Tumours.

Authors:  Zhelin Xia; Fanhua Kong; Kunpeng Wang; Xin Zhang
Journal:  Front Pharmacol       Date:  2022-06-09       Impact factor: 5.988

4.  FTO promotes liver inflammation by suppressing m6A mRNA methylation of IL-17RA.

Authors:  Xiaojie Gan; Zhihui Dai; Chunmei Ge; Haozan Yin; Yuefan Wang; Jian Tan; Shuhan Sun; Weiping Zhou; Shengxian Yuan; Fu Yang
Journal:  Front Oncol       Date:  2022-09-12       Impact factor: 5.738

Review 5.  Dissimilar Appearances Are Deceptive-Common microRNAs and Therapeutic Strategies in Liver Cancer and Melanoma.

Authors:  Lisa Linck-Paulus; Claus Hellerbrand; Anja K Bosserhoff; Peter Dietrich
Journal:  Cells       Date:  2020-01-02       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.